Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesAuxly Cannabis Group Inc

Auxly Cannabis Group Inc

Healthcare Drug Manufacturers - Specialty & Generic
PortfolioPortfolio WatchlistWatchlist
Company price
3.72 CAD 0.04 ( 1.09%)
Last update at 2026-11-04T20:33:00Z
VOLUME
54005
Market Cap
182.66M
P/E
4.33

Momentum Score

…

Auxly Cannabis Group Inc. operates as a consumer packaged goods company in the cannabis products market in Canada. The company offers cannabis products under various forms, including milled and dried flowers, vape cartridges, infused pre-rolls, pre-rolled, all- in-one vapes, edibles, concentrates, oils, and softgels under the KOLAB PROJECT, Dosecann, BACK FORTY, Foray, and Parcel brand names. It sells its products through supply arrangements with provincial control boards and distributors, medical cannabis sales channels, and retailers, as well as to authorized wholesalers. The company was formerly known as Cannabis Wheaton Income Corp. and changed its name to Auxly Cannabis Group Inc. in June 2018. Auxly Cannabis Group Inc. was incorporated in 1987 and is headquartered in Toronto, Canada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
3.68
Low
3.77
High
52 Week Price Range
0.07
Low
0.19
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Auxly Cannabis Group is a Canadian licensed producer and consumer-packaged cannabis company that develops, manufactures and distributes cannabis products for medical and adult-use markets in Canada and select international jurisdictions. Long-term growth may be supported by expansion of legal markets, product and brand development, and industry consolidation, and the company appears positioned to benefit from rising demand for packaged cannabis offerings.

Primary investment risks include ongoing industry oversupply and pricing pressure, persistent unprofitability and capital constraints, plus regulatory and licensing uncertainty that could limit market access or increase compliance costs.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
3.68
Dividend Yield
-
Revenue TTM
151.48M
Revenue Per Share
0.11
Gross Profit TTM
86.74M
Debt / Equity
0.32
ROE
28.55%
Net Debt
25.12M
ROCE
-10.79%
Diluted EPS TTM
0.03

Insight News

View All

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 32.52M -0.36M -47.75M -136.56M -50.24M
Minority interest - - - 0.00M 0.01M
Net income 41.85M -16.35M -44.51M -130.29M -45.91M
Selling general administrative 49.07M 29.78M 39.78M 37.54M 36.12M
Selling and marketing expenses - 10.95M 0.50M 13.13M 9.60M
Gross profit 24.64M 59.93M 21.28M 17.92M 19.29M
Reconciled depreciation 11.45M 10.28M 11.21M 21.58M 14.27M
Ebit -24.43M 14.10M -22.10M -46.79M -42.01M
Ebitda -12.98M 24.38M -10.89M -25.22M -27.73M
Depreciation and amortization 11.45M 10.28M 11.21M 21.58M 14.27M
Operating income -24.43M 14.71M -19.00M -46.79M -42.01M
Other operating expenses 175.91M 107.61M 120.08M 142.04M 122.77M
Interest expense 6.66M 15.04M 25.71M 21.58M 17.67M
Tax provision -9.34M 15.99M -3.24M -6.26M -4.33M
Interest income 0.13M 0.98M 0.03M 0.34M 3.85M
Net interest income -6.53M -14.80M -25.68M -21.24M -16.08M
Extraordinary items - - - 0.00M 12.16M
Income tax expense -9.34M 15.99M -3.24M -6.26M -4.33M
Total revenue 151.48M 122.33M 101.08M 94.47M 83.83M
Total operating expenses 49.07M 45.22M 40.28M 65.49M 58.23M
Cost of revenue 126.84M 62.40M 79.80M 76.55M 64.54M
Total other income expense net 56.95M -15.07M -28.74M -89.76M -8.23M
Discontinued operations - - - - 12.16M
Net income from continuing ops 41.85M -16.35M -44.51M -130.29M -45.91M
Net income applicable to common shares - -16.35M -44.51M -130.29M -33.74M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 271.64M 261.53M 261.90M 331.82M 450.42M
Intangible assets 28.21M 29.76M 29.88M 45.47M 74.20M
Other current assets 1.84M - 1.52M 3.13M 14.93M
Total liab 94.06M 145.87M 210.86M 246.13M 242.31M
Total stockholder equity 177.58M 115.66M 51.05M 90.41M 212.52M
Other current liab 0.27M 3.75M 0.49M 0.71M 1.30M
Common stock 549.56M - 446.56M 444.76M 436.51M
Capital stock 549.56M 542.63M 446.56M 444.76M 436.51M
Retained earnings -457.76M -499.62M -483.27M -438.76M -308.47M
Other liab - - - - 20.04M
Good will - - - 0.00M 24.29M
Other assets - - - 0.09M 1.58M
Cash 32.53M 18.36M 16.16M 14.64M 14.75M
Cash and equivalents - - - 14.64M 14.75M
Total current liabilities 45.13M 123.29M 106.97M 92.69M 53.65M
Current deferred revenue 0.35M - 0.00M - 0.29M
Net debt 25.12M 36.33M 142.88M 178.96M 175.35M
Short term debt 8.72M - 65.18M 58.93M 21.49M
Short long term debt 6.12M 51.60M 61.35M 54.67M 17.45M
Short long term debt total 57.65M - 159.04M 193.59M 190.10M
Other stockholder equity 42.93M - 39.50M -30.54M 44.85M
Property plant equipment - - - 195.27M 226.48M
Total current assets 99.24M 76.61M 65.99M 89.90M 119.97M
Long term investments 0.26M 0.59M 1.09M 1.09M 3.90M
Net tangible assets - - - - 114.03M
Short term investments 0.14M 0.14M 0.14M 0.14M 0.14M
Net receivables 22.38M 21.75M 16.73M 17.53M 31.21M
Long term debt 40.16M 3.09M 81.38M 119.80M 151.36M
Inventory 42.34M 34.00M 31.43M 54.46M 58.94M
Accounts payable 35.80M 44.90M 41.30M 33.05M 30.57M
Accumulated other comprehensive income 42.86M - 48.26M 84.41M 84.48M
Non currrent assets other 0.29M - 5.98M 0.09M 1.58M
Non current assets total 172.40M 184.92M 195.92M 241.92M 330.45M
Capital lease obligations 11.37M 13.79M 16.31M 19.12M 21.30M
Long term debt total - - - 134.67M 168.61M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments 0.00M -0.45M -1.56M 1.18M 9.34M
Change to liabilities - - - 2.87M 0.18M
Total cashflows from investing activities -2.46M -0.45M -1.56M 1.18M 17.33M
Net borrowings -10.56M -14.48M -8.39M - -19.55M
Total cash from financing activities -9.81M -13.59M -5.68M 1.18M 26.40M
Change to operating activities - - - 9.98M -6.26M
Net income 41.85M -16.35M -44.51M -130.29M -45.91M
Change in cash 13.62M 2.75M 0.97M -0.12M -5.90M
Begin period cash flow 18.91M 15.61M 15.19M 14.75M 20.66M
End period cash flow 32.53M 18.36M 16.16M 14.64M 14.75M
Total cash from operating activities 25.89M 16.78M 8.21M -2.48M -49.63M
Issuance of capital stock - 0.00M 3.13M 7.94M 44.94M
Depreciation 11.45M 10.28M 11.21M 21.58M 14.27M
Other cashflows from investing activities - 2.22M 0.05M 10.37M -0.00M
Change to inventory -3.25M 1.57M 12.71M -3.21M -6.93M
Change to account receivables 0.13M -5.83M 0.80M 10.41M -16.65M
Sale purchase of stock - 1.50M 3.13M 7.94M 46.15M
Other cashflows from financing activities -2.42M -0.61M -0.43M 15.51M 49.27M
Change to netincome - - - - -0.51M
Capital expenditures 2.52M 2.76M 1.60M 9.19M 0.38M
Change in working capital -12.68M -0.05M 17.86M 20.04M -29.66M
Stock based compensation 5.26M 5.04M 1.64M 4.02M 1.43M
Other non cash items -14.74M 1.87M 25.25M 88.43M 14.56M
Free cash flow 23.37M 14.02M 6.61M -11.67M -50.01M

Peer Comparison*

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Stock Name
Change
(CAD)
Price
(CAD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
XLY
Auxly Cannabis Group Inc		 0.04
1.09%		 3.72 4.33 11.67 1.21 1.11 1.47 4.41
CURA
Curaleaf Holdings Inc.		 -0.74
5.20%		 13.49 - 138.89 2.57 3.14 2.47 13.10
BHC
Bausch Health Companies Inc		 0.31
2.72%		 11.72 13.98 1.35 0.28 18.74 2.12 6.84
CRON
Cronos Group Inc		 0.16
3.36%		 4.92 - 32.15 9.80 0.95 1.47 1.90
TLRY
Tilray Inc		 0.41
11.02%		 4.13 - 1000.00 1.28 0.53 1.08 -2.30

Profile*

Auxly Cannabis Group Inc

Auxly Cannabis Group Inc. operates as a consumer packaged goods company in the cannabis products market in Canada. The company offers cannabis products under various forms, including milled and dried flowers, vape cartridges, infused pre-rolls, pre-rolled, all- in-one vapes, edibles, concentrates, oils, and softgels under the KOLAB PROJECT, Dosecann, BACK FORTY, Foray, and Parcel brand names. It sells its products through supply arrangements with provincial control boards and distributors, medical cannabis sales channels, and retailers, as well as to authorized wholesalers. The company was formerly known as Cannabis Wheaton Income Corp. and changed its name to Auxly Cannabis Group Inc. in June 2018. Auxly Cannabis Group Inc. was incorporated in 1987 and is headquartered in Toronto, Canada.

777 Richmond Street West, Toronto, ON, Canada, M6J 0C2

833-695-2414

https://www.auxly.com

446

Name Title Year Born
Mr. Hugo M. Alves CEO & Director 1972
Mr. Michael David Lickver Pres 1986
Mr. Brian Schmitt Chief Financial Officer NA
Mr. Ron Fichter Gen. Counsel & Corp. Sec. NA
Mr. Andrew MacMillan Sr. VP of Commercial NA
Mr. Alan Cooke Sr. VP of Operations NA
Ms. Carla Nawrocki Sr. VP of Corp. Devel. & Strategy NA
Mr. Ian Peter Rapsey Chief Creative Officer 1977
Mr. Kevin Furet Chief Cultivation & Genetics Officer NA
Mr. Vladimir Klacar Sr. VP of Regulatory Affairs & Planning 1989

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

PRL
CAD 30.50
+15.05%
DSV
CAD 11.02
+14.55%
USA
CAD 4.29
+13.19%
NUAG
CAD 7.70
+12.90%
GMIN
CAD 43.79
+12.86%
DRUG
CAD 26.11
-29.58%
HUT
CAD 68.98
-22.41%
UCU
CAD 2.09
-14.34%
VET
CAD 14.87
-14.29%
PHX
CAD 10.96
-13.56%

Equity Sectors*

  • Basic Materials

    +5.46%

  • Communication Services

    +3.38%

  • Consumer Cyclical

    +3.11%

  • Consumer Defensive

    +1.35%

  • Energy

    -4.79%

  • Financial Services

    +2.66%

  • Healthcare

    -0.72%

  • Industrials

    -0.11%

  • Real Estate

    +1.84%

  • Technology

    +1.05%

  • Utilities

    +0.39%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…